Leibowitz Arthur S 4

What Happened
Arthur S. Leibowitz, a director of Organogenesis Holdings, purchased 5,000 shares of Organogenesis common stock in an open-market/private purchase (Form 4 code P) on March 9, 2026. The shares were acquired at $2.68 per share for a total transaction value of $13,405. This was a purchase (buy), which investors often view as a more informative insider action than routine sales.

Key Details

• Transaction date: 2026-03-09
• Price per share: $2.68; Shares acquired: 5,000; Total value: $13,405
• Transaction type: Purchase (Form 4 code P — open market or private purchase)
• Shares owned after the transaction: not specified in the provided summary (see the SEC Form 4 for total holdings)
• Filing date: 2026-03-11 (filed within the typical two-business-day window; not reported late)
• No footnotes, 10b5-1 plan, or tax-withholding details were provided in the summary

Context
Insider purchases can indicate confidence but do not prove future performance. This is a relatively small dollar purchase ($13.4k) by a director. For complete details (total holdings, exact transaction method, and any footnotes), review the full Form 4 filing on the SEC website (Accession: 0002064832-26-000129).